CASSANDRA KESSLER: Open Payments
NPI 1447760251 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 27 payments from 8 companies in 2025. Trend: 2023 $367 · 2024 $1,300 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $263 |
| Dendreon Pharmaceuticals LLC | 4 | $235 |
| PFIZER INC. | 5 | $195 |
| Janssen Biotech, Inc. | 3 | $48 |
| UROGEN PHARMA, INC. | 2 | $35 |
| ACCORD HEALTHCARE, INC. | 2 | $30 |
| Endo USA, Inc. | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
Products named: PROVENGE, XTANDI, GEMTESA, ORGOVYX, ERLEADA, Camcevi, JELMYTO, AVEED.
Industry payments across OH — which companies pay providers there.
